SYRE Chart
See on advanced chart >
About
Spyre Therapeutics, Inc. was converted from a Delaware LLC on December 16, 2013. The Company is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering,...
Read More
- HighlightA clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of rare metabolic diseases
- ExchangeNASDAQ
- Listing Date04/07/2016
- Established Date12/16/2013
- Full-time Employees30
- Address221 Crescent Street Building 23 Suite 105 Waltham Massachusetts 02453
- Tel1-617-6515940
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology